Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 9/20 | 0.35 |
| ▸ | ABL1 | P00519 | 2/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21717870 | 0.91 | ENPP3 (0.39) | PTGER4CYP11B1CYP11B2ENPP3ABL1 | |
| SCHEMBL21717346 | 0.90 | PTGER4 (0.37) | PTGER4CYP11B1CYP11B2ALKBH5FTO | |
| SCHEMBL21710702 | 0.88 | CA1 (0.37) | PTGER4CYP11B1CYP11B2ENPP3ABL1 | |
| SCHEMBL21710470 | 0.85 | ENPP3 (0.40) | PTGER4CYP11B1CYP11B2ENPP3RORC | |
| SCHEMBL21710482 | 0.84 | PTGER4 (0.38) | PTGER4CYP11B1CYP11B2ENPP3RORC | |
| SCHEMBL22858124 | 0.84 | ENPP3 (0.38) | PTGER4CYP11B1CYP11B2ENPP3RORC | |
| SCHEMBL21710649 | 0.84 | PTGER4 (0.39) | PTGER4ALKBH5FTOENPP3RORC | |
| SCHEMBL21710647 | 0.83 | PTGER4 (0.41) | PTGER4ENPP3RORC | |
| SCHEMBL21717825 | 0.83 | ENPP3 (0.43) | PTGER4ENPP3RORCALDH1A1DUSP3 | |
| SCHEMBL38652911 | 0.83 | ENPP3 (0.43) | PTGER4ENPP3RORCALDH1A1DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029119-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20200365812-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-11-19 | — | — | US | disclosed |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029119-B2 | Organic electroluminescence element and electronic device | LEF1, L1CAM, ESR2 | PTGER4 2157/4885CYP11B1 1468/4885CYP11B2 1438/4885 |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | PTGER4 2157/4885CYP11B1 1468/4885CYP11B2 1438/4885 |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | OR51E2, CD99, CTNND1 | PTGER4 3243/4885CYP11B1 1193/4885CYP11B2 705/4885 |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | EML4, EBPL, LEF1 | PTGER4 4325/4885CYP11B1 2860/4885CYP11B2 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.